| 000 | 01432 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250514023454.0 | ||
| 264 | 0 | _c20020520 | |
| 008 | 200205s 0 0 eng d | ||
| 022 | _a0269-9370 | ||
| 024 | 7 |
_a10.1097/00002030-200202150-00034 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aColson, Philippe | |
| 245 | 0 | 0 |
_aTransmission of HIV-1 variants resistant to the three classes of antiretroviral agents: implications for HIV therapy in primary infection. _h[electronic resource] |
| 260 |
_bAIDS (London, England) _cFeb 2002 |
||
| 300 |
_a507-9 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 | _aAmino Acid Substitution |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aDrug Resistance, Multiple, Viral _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenetic Variation |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHIV Protease _xgenetics |
| 650 | 0 | 4 |
_aHIV Reverse Transcriptase _xgenetics |
| 650 | 0 | 4 |
_aHIV-1 _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMutation |
| 700 | 1 | _aRavaux, Isabelle | |
| 700 | 1 | _aYahi, Nouara | |
| 700 | 1 | _aTourrès, Christian | |
| 700 | 1 | _aGallais, Hervé | |
| 700 | 1 | _aTamalet, Catherine | |
| 773 | 0 |
_tAIDS (London, England) _gvol. 16 _gno. 3 _gp. 507-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00002030-200202150-00034 _zAvailable from publisher's website |
| 999 |
_c11744049 _d11744049 |
||